NCT02371681View on ClinicalTrials.gov

NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis

PHASE2CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

February 25, 2015

Primary Completion Date

September 1, 2017

Study Completion Date

November 14, 2017

Conditions
Pulmonary Tuberculosis
Interventions
DRUG

Treatment

Different Drug combinations

RADIATION

PET/CT Scan

PET/CT Scans

PROCEDURE

Sample Collection

Sample Collection

Trial Locations (2)

Unknown

Stellenbosch University, Faculty of Medicine and Health Sciences, Cape Town

TASK Applied Sciences, Cape Town

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02371681 - NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis | Biotech Hunter | Biotech Hunter